Qiu Sun
State Key Laboratory Of Biotherapy And Cancer Center
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Structure-Guided Optimization of p62-Directed AUTOTACs for Efficient EGFR/VEGFR2 Degradation and Antitumor Efficacy.
Journal: Journal of medicinal chemistry
Published: July 21, 2026
Application and Reflection of Artificial Intelligence in Pharmacy Education
Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Published: December 11, 2025
Reprogramming macrophage immunometabolism via glutamine antagonism potentiates colorectal cancer therapy in mice.
Journal: Nature communications
Published: September 03, 2025
Multiscale biased chemical space remodeling for developing APLNR agonists with anti-HFpEF efficacy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 02, 2025
Identification of a Selective YTHDF1 Inhibitor Targeting the m6A Recognition Domain for Breast Cancer.
Journal: Angewandte Chemie (International ed. in English)
Published: April 28, 2025
Avian GCGR-mediated continuous fat utilization offers perspectives for obesity treatment.
Journal: Nature communications
Published: January 29, 2025
Discovery of 3-indolylbenzoquinone derivatives with therapeutic potential for breast cancer.
Journal: Bioorganic & medicinal chemistry
Published: November 23, 2024
A first-in-class selective inhibitor of ERK1/2 and ERK5 overcomes drug resistance with a single-molecule strategy.
Journal: Signal transduction and targeted therapy
Published: October 12, 2024
Boosting Med Chem Education: Integrating Biology for Drug Discovery Talents.
Journal: Journal of medicinal chemistry
Published: September 24, 2024
Acquired resistance to tyrosine kinase targeted therapy: mechanism and tackling strategies.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: September 17, 2024
Selective Covalent Inhibiting JNK3 by Small Molecules for Parkinson's Diseases.
Journal: Angewandte Chemie (International ed. in English)
Published: June 12, 2024
Strategies and techniques for preclinical therapeutic targeting of PI3K in oncology: where do we stand in 2024?
Journal: Expert opinion on therapeutic targets
Published: April 22, 2024
Last Updated: 09/26/2026